These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 36846943)
1. ELF1 suppresses autophagy to reduce cisplatin resistance via the miR-152-3p/NCAM1/ERK axis in lung cancer cells. Zhao L; Wu X; Zhang Z; Fang L; Yang B; Li Y Cancer Sci; 2023 Jun; 114(6):2650-2663. PubMed ID: 36846943 [TBL] [Abstract][Full Text] [Related]
2. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway. Xiao XH; He SY Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431 [TBL] [Abstract][Full Text] [Related]
3. CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis. Zhong Y; Lin H; Li Q; Liu C; Shen J Cancer Biomark; 2021; 30(2):261-273. PubMed ID: 33682697 [TBL] [Abstract][Full Text] [Related]
4. The malignant property of circHIPK2 for angiogenesis and chemoresistance in non-small cell lung cancer. Ren M; Song X; Niu J; Tang G; Sun Z; Li Y; Kong F Exp Cell Res; 2022 Oct; 419(2):113276. PubMed ID: 35863454 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p. Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146 [TBL] [Abstract][Full Text] [Related]
6. Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis. Chu D; Li P; Li Y; Shi J; Huang S; Jiao P Thorac Cancer; 2021 Nov; 12(21):2894-2906. PubMed ID: 34523261 [TBL] [Abstract][Full Text] [Related]
7. NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis. Huang Q; Xing S; Peng A; Yu Z Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894841 [TBL] [Abstract][Full Text] [Related]
8. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells. Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212 [TBL] [Abstract][Full Text] [Related]
9. MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2. Liu Y; Zhang Y; Li Q; Xu R; Huang N Thorac Cancer; 2022 Jul; 13(13):1974-1985. PubMed ID: 35599447 [TBL] [Abstract][Full Text] [Related]
10. Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5). Wei D; Zeng J; Rong F; Xu Y; Wei R; Zou C Bioengineered; 2022 Mar; 13(3):5126-5140. PubMed ID: 35170372 [TBL] [Abstract][Full Text] [Related]
11. Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy. Ma Y; Yuwen D; Chen J; Zheng B; Gao J; Fan M; Xue W; Wang Y; Li W; Shu Y; Xu Q; Shen Y Int J Nanomedicine; 2019; 14():8121-8132. PubMed ID: 31632022 [TBL] [Abstract][Full Text] [Related]
12. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis. Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072 [TBL] [Abstract][Full Text] [Related]
14. LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4. Hu B; Zhang H; Wang Z; Zhang F; Wei H; Li L Cancer Biol Ther; 2017 Dec; 18(12):974-983. PubMed ID: 29020498 [TBL] [Abstract][Full Text] [Related]
15. miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549. Deng SH; Wu DM; Li L; Liu T; Zhang T; Li J; Yu Y; He M; Zhao YY; Han R; Xu Y Biochem Biophys Res Commun; 2021 Apr; 549():54-60. PubMed ID: 33662669 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung cancer cells by inhibiting autophagy related 3-mediated autophagy. Hua L; Zhu G; Wei J Cell Biol Int; 2018 Sep; 42(9):1240-1249. PubMed ID: 29851226 [TBL] [Abstract][Full Text] [Related]
17. Long non‑coding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR‑514a‑3p/ULK1 axis in human non‑small cell lung cancer. Shen Q; Xu Z; Xu S Int J Oncol; 2020 Oct; 57(4):967-979. PubMed ID: 32945379 [TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis. Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110 [TBL] [Abstract][Full Text] [Related]
19. LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis. Wang L; Shang X; Feng Q Cancer Biol Ther; 2019; 20(3):261-271. PubMed ID: 30481109 [TBL] [Abstract][Full Text] [Related]
20. Cisplatin resistance and malignant behaviors of lung cancer cells are promoted by circ_0002360 via targeting miR-6751-3p to regulate the expression of ZNF300. Ding L; Li L; Tang Z Thorac Cancer; 2022 Apr; 13(7):986-996. PubMed ID: 35166026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]